Hamilton plans peripheral arterial disease mhealth pilot
November 7, 2016
Hamilton Health Sciences and McMaster University in Ontario are to pilot remote patient monitoring and care collaboration starting in February next year for patients with peripheral arterial disease.
The technology comes from mhealth and telemedicine company Reliq Health Technologies, based in Vancouver.
"We are very excited to work with Hamilton Health Sciences and McMaster University to improve health outcomes for patients with peripheral arterial disease," said Lisa Crossley, CEO of Reliq Health. “Our collaboration with McMaster and HHS will allow us to deliver digital health for self-care and patient education that is uniquely tailored to the needs of these outpatients. Our platform uses a high tech, low touch approach to provide high quality healthcare in the home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction."
Peripheral arterial disease affects over 800,000 Canadians and more than eight million Americans. PAD can cause pain, fatigue, poor circulation and slow wound healing in the extremities. Unless properly managed, PAD can lead to significant complications including infection, gangrene and amputations.
Reliq Health's proprietary hardware and software supports patients and their caregivers in the home, providing remote monitoring with alerts to clinicians as needed, audible reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored digital patient education materials, and secure communications with the entire care team.
Studies have consistently shown that providing patients and families with the tools they need to understand and manage their clinical conditions at home leads to better health outcomes.